News

Combining duvelisib and romidepsin may provide a path to stem cell transplant for patients with relapsed or refractory peripheral and cutaneous T-cell lymphomas.  Researchers from Somerville, ...
An experimental mRNA vaccine that supercharges existing cancer treatments could be laying the groundwork for a “universal” cancer vaccine, according to the team behind the breakthrough. Scientists at ...
The efficacy of CAR-T cells in ablating solid tumors is significantly impeded by the densely packed tumor extracellular matrix (ECM). This physical ...
A team of researchers from the Changchun Institute of Applied Chemistry has developed a nanogel-based strategy to enhance the ...
In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...
Researchers are building on the success of CAR T therapy in blood cancers to explore its use in clear cell renal cell ...
A personalized neoantigen vaccine may be effective in patients with clear cell renal cell carcinoma, shared David A. Braun, ...
Intratumoral microbiota—the microbial populations residing within solid tumors—have emerged as pivotal components of the tumor microenvironment (TME ...
The field of oncology has been revolutionized by the introduction of immune checkpoint inhibitors, with anti-PD-1 therapies offering durable responses in ...
The National Cancer Center Research Institute in Tokyo reports that a newly isolated gut bacterium, designated ...
Prof. LIANG Xingjie's team from the National Center for Nanoscience and Technology, along with Prof. GONG Ningqiang from the University of Science and Technology of China, has developed a biomimetic ...
Promising therapeutic strategies for lung cancer, AML and advanced solid tumors Novel insights into ovarian cancer, blood disorders and chemotherapy-related secondary cancers New-onset diabetes as an ...